Search research articles
Contact Us
Filters
Showing results (51-60 of 102) with videos related to
Page
of 11
Sort By:
Journal of Neuroimmunology
|
November 5, 2003
The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta
Sarah Shapiro, Yanina Galboiz, Nitza Lahat, et al.
Journal of Autoimmunity
|
December 24, 2013
Genetic basis of myasthenia gravis - a comprehensive review
Nili Avidan, Rozen Le Panse, Sonia Berrih-Aknin, et al.
Journal of the Neurological Sciences
|
December 6, 2011
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
Lena Melamud, Daniel Golan, Rafael Luboshitzky, et al.
Journal of the Neurological Sciences
|
December 14, 2002
Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis
Sarah Shapiro, Ariel Miller, Nitza Lahat, et al.
European Neurology
|
June 9, 2005
Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease
Michael Inspector, Judith Aharon-Perez, Lea Glass-Marmor, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 24, 2006
Chronotherapy using corticosteroids for multiple sclerosis relapses
Lea Glass-Marmor, Tamar Paperna, Yaara Ben-Yosef, et al.
International Journal of Molecular Sciences
|
May 4, 2026
Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments
Elsebeth Staun-Ram, Anat Volkowich, Lea Glass-Marmor, et al.
Drug News & Perspectives
|
April 5, 2003
Pharmacogenetic Development of Personalized Medicine: Multiple Sclerosis Treatment as a Model
Iris Kirstein-Grossman, Jacques S. Beckmann, Doron Lancet, et al.
Multiple Sclerosis International
|
November 19, 2011
Internet usage by patients with multiple sclerosis: implications to participatory medicine and personalized healthcare
Izabella Lejbkowicz, Tamar Paperna, Nili Stein, et al.
Journal of Neuroimmunology
|
May 12, 2005
Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells
Michal Abraham, Sarah Shapiro, Arnon Karni, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 102) with videos related to
Sort By:
Page
of 11
Journal of Neuroimmunology
|
November 5, 2003
The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta
Sarah Shapiro, Yanina Galboiz, Nitza Lahat, et al.
Journal of Autoimmunity
|
December 24, 2013
Genetic basis of myasthenia gravis - a comprehensive review
Nili Avidan, Rozen Le Panse, Sonia Berrih-Aknin, et al.
Journal of the Neurological Sciences
|
December 6, 2011
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
Lena Melamud, Daniel Golan, Rafael Luboshitzky, et al.
Journal of the Neurological Sciences
|
December 14, 2002
Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis
Sarah Shapiro, Ariel Miller, Nitza Lahat, et al.
European Neurology
|
June 9, 2005
Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease
Michael Inspector, Judith Aharon-Perez, Lea Glass-Marmor, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 24, 2006
Chronotherapy using corticosteroids for multiple sclerosis relapses
Lea Glass-Marmor, Tamar Paperna, Yaara Ben-Yosef, et al.
International Journal of Molecular Sciences
|
May 4, 2026
Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments
Elsebeth Staun-Ram, Anat Volkowich, Lea Glass-Marmor, et al.
Drug News & Perspectives
|
April 5, 2003
Pharmacogenetic Development of Personalized Medicine: Multiple Sclerosis Treatment as a Model
Iris Kirstein-Grossman, Jacques S. Beckmann, Doron Lancet, et al.
Multiple Sclerosis International
|
November 19, 2011
Internet usage by patients with multiple sclerosis: implications to participatory medicine and personalized healthcare
Izabella Lejbkowicz, Tamar Paperna, Nili Stein, et al.
Journal of Neuroimmunology
|
May 12, 2005
Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells
Michal Abraham, Sarah Shapiro, Arnon Karni, et al.
Page
of 11